Please visit Dutch measures against COVID-19 and Travelling to the Netherlands from abroad websites before planning your visit.

Due to COVID restrictions only 300 delegates can be admitted to the RAI venue. Therefore, speakers and chairmen have been given priority for onsite registration in order to stimulate live interaction in the meeting halls.
Using high-end technology, the entire meeting will be streamed through the meeting webportal. The online public is invited to chat with the chairmen of the sessions and can react during the lectures as the delegates in the hall.

During breaks, interviews on controversial topics with stakeholders, patient representatives and speakers will be broadcast from the studio.
All the content will be accessible for 6 months after the meeting both for online and onsite participants.

COVID MEASURES inside the venue
• All delegates must be registered online before travelling to Amsterdam
• Registration documents can be picked up at the desk inside the building
• 1.5 meters distance in walking areas
• Limited capacity of meeting halls
• No physical contact
• Eating and drinking only when seated
• Regular disinfection, alcohol dispensers throughout the venue
• No masks required

COVID CHECK on entering the venue
• Vaccination status / negative COVID test checked on first entry every day
• Please allow some waiting time in peak hours early in the morning
EU-citizens use QR-code in EU Digital COVID Certificate + ID
Non-EU-citizens use written proof of vaccination with an EU-approved vaccine + ID
Non-vaccinated delegates need to be tested before entry every day + ID.
Testing facility on the premises [entrance R, address RAI P9, Wielingenstraat 5, 1078 KK Amsterdam].

Testing is free of charge, reservation required, result available within 2 hours.

The proof of vaccination must:
have been issued following vaccination with a vaccine that has been approved by the European Medicines Agency (EMA) or is on the Emergency Use Listing of the World Health Organization (WHO)
• have been issued based on full vaccination at least 2 weeks before the event
• the vaccination schedule consists of a single dose and this single dose has been administered (Janssen); or
• the vaccination schedule consists of two doses and:
1. both doses have been administered, or
2. one dose has been administered and it has been confirmed that the person vaccinated was infected with the virus SARS-CoV-2 no more than 6 months before the event (i.e. before March 15th, 2021).

• have been issued in one of the following languages:

• include the following: 
*information identifying the person who has been vaccinated;
*information demonstrating that the person in question has been fully vaccinated against the virus SARS-CoV-2;
*the name of the vaccine and the name of the manufacturer or marketing authorisation holder of each dose of the vaccine administered;
*the date on which each dose of the vaccine was administered;
*the name of the country in which the vaccine was administered;
*the name of the issuer of the proof of vaccination.

• Approved vaccines:
*Astra Zeneca (Vaxzevria)
*Pfizer-BioNTech (Comirnaty)
*Johnson & Johnson / Janssen (COVID-19 Vaccine)
*Moderna (Spikevax)
*Serum Institute of India (Covishield)
*Sinopharm BIBP

Summary of the RAI procedures click here
Please also check the most recent updates on COVID regulations by the Dutch health care authorities at